Literature DB >> 16816946

Cost-effectiveness of the Danish smoking cessation interventions: subgroup analysis based on the Danish Smoking Cessation Database.

Kim Rose Olsen1, Lone Bilde, Henrik Hauschildt Juhl, Niels Them Kjaer, Holger Mosbech, Torben Evald, Mette Rasmussen, Helle Hiladakis.   

Abstract

The cost-effectiveness of smoking cessation interventions is well documented. However, most studies are based on randomized controlled trials (RCTs) and provide little information on the differences between subgroups. This study assessed the relative cost-effectiveness of smoking cessation interventions offered to various subgroups of smokers, based on real-life data. Regression analyses provided information on the factors determining abstinence and costs and led to the formation of relevant subgroups of smokers. Probabilistic Markov modeling was then used to estimate the relative cost-effectiveness of smoking cessation interventions for the entire database population and for the subgroups compared to a no-intervention case. The ICER for the base case population was estimated at 1,358 euro. This is consistent with results from the existing literature. Group simulations showed lower ICERs for men, hospitals, and light smokers and falling ICERs with increasing age. Despite differences in the cost-effectiveness ratios between subgroups our results do not justify any kind of subgroup differentiation in a smoking prevention policy.

Entities:  

Mesh:

Year:  2006        PMID: 16816946     DOI: 10.1007/s10198-006-0362-1

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  7 in total

Review 1.  Economic evaluation of smoking-cessation therapies: a critical and systematic review of simulation models.

Authors:  Kristian Bolin
Journal:  Pharmacoeconomics       Date:  2012-07-01       Impact factor: 4.981

2.  Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions.

Authors:  Denis Getsios; Jenő P Marton; Nikhil Revankar; Alexandra J Ward; Richard J Willke; Dale Rublee; K Jack Ishak; James G Xenakis
Journal:  Pharmacoeconomics       Date:  2013-09       Impact factor: 4.981

3.  Gold standard program for heavy smokers in a real-life setting.

Authors:  Tim Neumann; Mette Rasmussen; Berit L Heitmann; Hanne Tønnesen
Journal:  Int J Environ Res Public Health       Date:  2013-09-09       Impact factor: 3.390

4.  The Gold Standard Programme: smoking cessation interventions for disadvantaged smokers are effective in a real-life setting.

Authors:  Tim Neumann; Mette Rasmussen; Nermin Ghith; Berit L Heitmann; Hanne Tønnesen
Journal:  Tob Control       Date:  2012-06-16       Impact factor: 7.552

Review 5.  Model-based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review.

Authors:  Marrit L Berg; Kei Long Cheung; Mickaël Hiligsmann; Silvia Evers; Reina J A de Kinderen; Puttarin Kulchaitanaroaj; Subhash Pokhrel
Journal:  Addiction       Date:  2017-02-15       Impact factor: 6.526

6.  Effectiveness of the Gold Standard Programme compared with other smoking cessation interventions in Denmark: a cohort study.

Authors:  Mette Rasmussen; Esteve Fernández; Hanne Tønnesen
Journal:  BMJ Open       Date:  2017-02-27       Impact factor: 2.692

7.  Is population screening for abdominal aortic aneurysm cost-effective?

Authors:  Lars Ehlers; Jan Sørensen; Lotte Groth Jensen; Merete Bech; Mette Kjølby
Journal:  BMC Cardiovasc Disord       Date:  2008-11-18       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.